Redeł Anna, Binkowska Alicja Anna, Obarska Katarzyna, Marcowski Przemysław, Szymczak Karol, Lewczuk Karol, Solich Katarzyna, Banaszak Maria, Woronowicz Bohdan, Nowicka Małgorzata, Skorko Maciej, Gola Mateusz, Bielecki Maksymilian
PredictWatch, Białystok, Poland.
Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Front Psychiatry. 2024 May 8;15:1335105. doi: 10.3389/fpsyt.2024.1335105. eCollection 2024.
Substance Use Disorder (SUD) persists as a significant public health challenge worldwide, with an estimated prevalence of approximately 10-15% across the global populace. This condition is characterized by a notably high risk of lapses and relapses, even subsequent to treatment interventions. Mobile health interventions, owing to their widespread accessibility, emerge as a promising approach to diminish the risk of relapse post-treatment and to broaden the scope of care, especially in regions with a scarcity of trained medical professionals.
This study is designed to assess the effectiveness of mobile interventions in mitigating cravings and preventing lapses among individuals diagnosed with SUD. Employing a two-armed, randomized controlled trial framework, the study will evaluate a self-administered psychological intervention delivered through a mobile application, Nałogometr 2.0. Over a period of three months, participants will engage with intervention modules that primarily incorporate mindfulness techniques and Cognitive Behavioral Therapy (CBT) principles. Ecological Momentary Assessment (EMA) will be utilized to gather longitudinal data on a range of variables that are indicative of craving intensity and the risk of lapse. In addition to this, a monthly-administered battery of questionnaires will be employed to gauge the severity of substance dependence, as well as to measure levels of anxiety, depression, and overall life satisfaction.
Results will be submitted for publication in peer-reviewed journals.
https://clinicaltrials.gov/, identifier [NCT05730504].
物质使用障碍(SUD)仍然是全球一项重大的公共卫生挑战,全球人口中的估计患病率约为10-15%。这种情况的特点是即使在治疗干预之后,复发和复吸的风险也非常高。移动健康干预由于其广泛的可及性,成为一种有前景的方法,可降低治疗后复发的风险并扩大护理范围,特别是在缺乏训练有素的医疗专业人员的地区。
本研究旨在评估移动干预对减轻被诊断为SUD的个体的渴望和预防复吸的有效性。采用双臂随机对照试验框架,该研究将评估通过移动应用程序Nałogometr 2.0提供的自我管理心理干预。在三个月的时间里,参与者将参与主要包含正念技巧和认知行为疗法(CBT)原则的干预模块。生态瞬时评估(EMA)将用于收集一系列表明渴望强度和复吸风险的变量的纵向数据。除此之外,每月发放一次的问卷组将用于评估物质依赖的严重程度,以及测量焦虑、抑郁和总体生活满意度水平。
结果将提交至同行评审期刊发表。
https://clinicaltrials.gov/,标识符 [NCT05730504]。